Cargando…
Leishmania is not prone to develop resistance to tamoxifen
Tamoxifen, an antineoplastic agent, is active in vitro and in vivo against the parasitic protozoa Leishmania. As part of our efforts to unravel this drug's mechanisms of action against the parasite and understand how resistance could arise, we tried to select tamoxifen-resistant Leishmania amaz...
Autores principales: | Coelho, Adriano C., Trinconi, Cristiana T., Senra, Luisa, Yokoyama-Yasunaka, Jenicer K.U., Uliana, Silvia R.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486464/ https://www.ncbi.nlm.nih.gov/pubmed/26150922 http://dx.doi.org/10.1016/j.ijpddr.2015.05.006 |
Ejemplares similares
-
Tamoxifen Is Effective in the Treatment of Leishmania amazonensis Infections in Mice
por: Miguel, Danilo C., et al.
Publicado: (2008) -
Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania
por: Trinconi, Cristiana T., et al.
Publicado: (2018) -
Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene
por: Reimão, Juliana Q., et al.
Publicado: (2014) -
In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis
por: Coelho, Adriano C., et al.
Publicado: (2014) -
In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up
por: Coelho, Adriano C., et al.
Publicado: (2016)